Stay updated with breaking news from Anna Padula. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.
-- In Three-Year Follow-up in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia, Tecartus Shows High Rates of Durable Response (CR+CRi 71%) and a Median Overall Survival of 26 Months
Yescarta® Now Approved in Japan for Initial Treatment of Relapsed/Refractory Large B-Cell Lymphoma
/PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) announced today that Kite, a Gilead Company has signed a two-year agreement to join LLS as the National...
Kite’s CAR T-cell Therapy Yescarta® First in Europe to Receive Positive CHMP Opinion for Use in Second-line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma